598 related articles for article (PubMed ID: 27746190)
21. Association Between Radiation Dose and Outcomes With Postoperative Radiotherapy for N0-N1 Non-Small Cell Lung Cancer.
Wang EH; Corso CD; Park HS; Chen AB; Wilson LD; Kim AW; Decker RH; Yu JB
Am J Clin Oncol; 2018 Feb; 41(2):152-158. PubMed ID: 26523443
[TBL] [Abstract][Full Text] [Related]
22. Postoperative radiotherapy with modern techniques does not improve survival for operable stage IIIA-N2 non-small cell lung cancer.
Predina J; Suliman R; Potter AL; Panda N; Diao K; Lanuti M; Muniappan A; Jeffrey Yang CF
J Thorac Cardiovasc Surg; 2023 May; 165(5):1696-1709.e4. PubMed ID: 36610886
[TBL] [Abstract][Full Text] [Related]
23. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
24. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis.
Kim BH; Kim HJ; Wu HG; Kang CH; Kim YT; Lee SH; Kim DW
Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882
[TBL] [Abstract][Full Text] [Related]
25. [Postoperative adjuvant therapy in combined lung cancer treatment].
Cicenas S; Piscikas DA; Jakubauskiene R
Medicina (Kaunas); 2004; 40 Suppl 1():156-60. PubMed ID: 15079128
[TBL] [Abstract][Full Text] [Related]
26. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma.
Tian C; Liu G; Xu Y; Xia G; Zhang T; Huang J; Jiang H; Ming Wang J; Li B
Radiol Oncol; 2020 Dec; 55(1):66-76. PubMed ID: 33885242
[TBL] [Abstract][Full Text] [Related]
27. Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase.
Liu J; Hancock JG; Moreno AC; Wang Z; Boffa DJ; Detterbeck FC; Kim AW
Eur J Cardiothorac Surg; 2016 Feb; 49(2):596-601. PubMed ID: 25890936
[TBL] [Abstract][Full Text] [Related]
28. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy.
Moretti L; Yu DS; Chen H; Carbone DP; Johnson DH; Keedy VL; Putnam JB; Sandler AB; Shyr Y; Lu B
Oncologist; 2009 Nov; 14(11):1106-15. PubMed ID: 19897534
[TBL] [Abstract][Full Text] [Related]
30. Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.
Osarogiagbon RU; Lin CC; Smeltzer MP; Jemal A
J Thorac Oncol; 2016 Jan; 11(1):e5-16. PubMed ID: 26762752
[TBL] [Abstract][Full Text] [Related]
31. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
[TBL] [Abstract][Full Text] [Related]
32. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
[TBL] [Abstract][Full Text] [Related]
33. Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy.
Wang W; Men Y; Wang J; Zhou Z; Chen D; Xiao Z; Feng Q; Lv J; Liang J; Bi N; Gao S; Wang L; Hui Z
BMC Cancer; 2019 May; 19(1):478. PubMed ID: 31113432
[TBL] [Abstract][Full Text] [Related]
34. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
35. The Role of Postoperative Radiation Therapy for pN2 Non-small-cell Lung Cancer.
Mankuzhy NP; Almahariq MF; Siddiqui ZA; Thompson AB; Grills IS; Guerrero TM; Lee KC; Stevens CW; Quinn TJ
Clin Lung Cancer; 2021 Jan; 22(1):e5-e17. PubMed ID: 32873482
[TBL] [Abstract][Full Text] [Related]
36. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS
J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815
[TBL] [Abstract][Full Text] [Related]
37. Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.
Wakeam E; Acuna SA; Leighl NB; Giuliani ME; Finlayson SRG; Varghese TK; Darling GE
Lung Cancer; 2017 Jul; 109():78-88. PubMed ID: 28577955
[TBL] [Abstract][Full Text] [Related]
38. The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.
Cox ML; Yang CJ; Speicher PJ; Anderson KL; Fitch ZW; Gu L; Davis RP; Wang X; D'Amico TA; Hartwig MG; Harpole DH; Berry MF
J Thorac Oncol; 2017 Apr; 12(4):689-696. PubMed ID: 28082103
[TBL] [Abstract][Full Text] [Related]
39. Effect of postoperative radiotherapy on outcome in resectable stage IIIA-N2 non-small-cell lung cancer: an updated meta-analysis.
Sakib N; Li N; Zhu X; Li D; Li Y; Wang H
Nucl Med Commun; 2018 Jan; 39(1):51-59. PubMed ID: 29189442
[TBL] [Abstract][Full Text] [Related]
40. Effects of Postoperative Radiotherapy on Survival of Patients With Stage IIIA Resected Non-Small Cell Lung Cancer: Analysis of the SEER Database.
Gao F; Li N; Xu Y; Yang G
J Natl Compr Canc Netw; 2020 Jun; 18(6):718-727. PubMed ID: 32502986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
